Ibaraki, Japan

Kiyoshi Yahiro

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyoshi Yahiro. Retrieved from https://idiyas.com/inventor/kiyoshi-yahiro-6848au4i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyoshi Yahiro: Innovator in Thiazolobenzoimidazole Derivatives

Introduction

Kiyoshi Yahiro is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on thiazolobenzoimidazole derivatives. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Kiyoshi Yahiro holds a patent for thiazolobenzoimidazole derivatives. This patent represents his commitment to creating new compounds that may have important applications in the pharmaceutical industry. His work in this area is a testament to his innovative spirit and technical knowledge.

Career Highlights

Yahiro is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to contribute to research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his impact on pharmaceutical innovations.

Collaborations

Throughout his career, Kiyoshi Yahiro has worked alongside esteemed colleagues such as Kyoichi Maeno and Masamichi Okada. These collaborations have enriched his research and have played a crucial role in the advancement of their shared goals in the pharmaceutical sector.

Conclusion

Kiyoshi Yahiro is a distinguished inventor whose work on thiazolobenzoimidazole derivatives has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…